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Abstract
Background: Metabolic syndrome (MetS) is characterized by systemic disturbances that increase cardiovascular risk.
Adiponectin (Ad) exhibits a cardioprotective function because of its anti-inflammatory and anti-atherosclerotic properties.
In the bloodstream, this adipocytokine circulates on multimers (Admer), among which high molecular weight (HMW) are
the most active forms. Because alterations of Ad plasmatic levels, Admer distribution and receptor (AdipoR) expression
have been described in murine models and obese patients, strategies that aim to enhance Ad production or its effect on
target tissues are the subject of intense investigations. While exercise training is well known to be beneficial for reducing
cardiovascular risk, the contribution of Ad is still controversial. Our aim was to evaluate the effect of exercise training on
Ad production, Admer distribution and AdipoR muscle expression in a murine model of MetS.
Methods: At 6 weeks of age, mice were submitted to a standard (SF) or high-fat high-sugar (HF) diet for 10 weeks. After
2 weeks, the SF- and HF-fed animals were randomly assigned to a training program (SFT, HFT) or not (SFC, HFC). The
trained groups were submitted to sessions of running on a treadmill 5 days a week.
Results and conclusions: The HF mice presented the key problems associated with MetS (increased caloric intake, body
weight, glycemia and fat mass), a change in Admer distribution in favor of the less-active forms and increased AdipoR2
expression in muscle. In contrast, exercise training reversed some of the adverse effects of a HF diet (increased glucose
tolerance, better caloric intake control) without any modifications in Ad production and Admer distribution. However,
increased AdipoR1 muscle expression was observed in trained mice, but this effect was hampered by HF diet. These data
corroborate a recent hypothesis suggesting a functional divergence between AdipoR1 and AdipoR2, with AdipoR1
having the predominant protective action on metabolic function.
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Background
Metabolic syndrome (MetS) is defined as a cluster of disor-
ders (abdominal obesity, insulin resistance, hypertension,
dyslipidemia) that lead to an increased risk of type 2
diabetes mellitus, cardiovascular disease and mortality [1].
Its prevalence is cause for increasing concern throughout
the world [1].
Adiponectin (Ad) is a 30-kDa protein mainly secreted
by adipose tissue. Because this adipocytokine exerts anti-
diabetic, anti-inflammatory and anti-atherogenic proper-
ties, increasing attention has been paid to the mechanism
through which it is modulated in MetS [2]. Hypoadipo-
nectinemia has been associated with both MetS and
various pathological states, such as obesity and diabetes.
Ad deficiency in mice results in inflammation [3], insulin
resistance [4–6] and heart failure [7]. In view of these
observations, Ad has been suggested as a promising and
easily detectable biological marker for MetS (reviewed in
[8]). Ad post-translational modifications result in multi-
meric forms (Admer) that are found in the bloodstream
and are classified as low (LMW), medium (MMW) and
high molecular weight (HMW). HMW forms are com-
monly considered the most biologically active because
they exert more potent AMPK activation and correlate
better with insulin sensitivity compared with LMW forms
(reviewed in [8]).
Ad is known to regulate lipid and glucose metabolism
through its AdipoR1 and AdipoR2 transmembrane re-
ceptors [9, 10]. AdipoR1 and AdipoR2 are ubiquitously
expressed, with the highest levels occurring in skeletal
muscle and the liver, respectively [11]. AdipoR1 has been
shown to act predominantly through the AMPK
signaling pathway, whereas AdipoR2 initiates PPAR-α
intracellular cascades. AdipoR1/AdipoR2 double-KO
mice present glucose intolerance and hyperinsulinemia,
demonstrating the key roles of these receptors in the
physiological regulation of glucose metabolism and insu-
lin sensitivity [10]. However, the respective functions of
AdipoR1 and AdipoR2 in vivo are still being investigated
[11]. In addition, T-cadherin, a GPI-anchored Ad-binding
protein expressed in endothelial cells, macrophages and
cardiomyocytes, was identified as an important mediator
of Ad’s cardiovascular protective actions [12, 13]. Interest-
ingly, in addition to the variation in Ad plasma levels
(Adpl), AdipoRs expression has been reported to be regu-
lated under physiological and pathological conditions. In-
deed, an increased AdipoR mRNA level was described in
the liver and skeletal muscle after fasting in mice [14].
Moreover, a reduced plasmatic HMW levels and
AdipoR1/2 expression in skeletal muscle and adipose tis-
sue were observed in diabetic patients and ob/ob mice, re-
spectively [14, 15]. Molecular mechanisms underlying
AdipoR regulation remain poorly known but it was shown
that insulin negatively regulates AdipoR mRNA, likely
through PI3-kinase/FoxO1 pathway [14]. As well, Park et
al. described that endoplasmic reticulum stress inducible
factor ATF3 (cyclic AMP-dependent Transcription Factor
3) may also act as a transcriptional repressor of AdipoRs
[16]. Post-transcriptional regulations are still currently
under investigation and may involve miRNA or alternative
splicing [17].
Consequently, strategies that aim to enhance Adpl and/or
activate AdipoR and/or post-receptor signaling pathways
are currently the subject of intense study [18]. AdipoR ago-
nists constitute promising pharmacotherapeutic approaches
for obesity-related diseases [19]. Among those, AdipoRON
[20] is very attractive because of its oral administration, its
high absorption and its delivery into relevant target tissues.
However, AdipoRON-induced intracellular signaling path-
ways are not fully characterized, and potential side effects
(ventricular hypertrophy, tumor growth, infertility) must be
further examined [19].
Although pharmacotherapy plays an important role in
the clinical treatment of obesity-associated problems
(hypertension, elevated LDL-cholesterol), physical activity
is now recognized as a therapeutic strategy for the
management of MetS [21, 22]. Exercise training is known
to reduce body weight, waist circumference, fat mass (par-
ticularly visceral fat), blood pressure and inflammation
[21–23]. Exercise training also improves insulin sensitivity
[23], lipid profile [24] as well as fasting plasma glucose
[22] and enhances β-cell function [21, 24]. However, the
contribution of the Ad pathway to these beneficial effects
remains unclear. In obese patients, Saunders et al. found
an increased Adpl level after 3 bouts of aerobic treadmill
exercise at either low or high intensity over a 1-week
period [25]. However, in elderly people with impaired
glucose tolerance, Bloem et al. did not observe any Adpl
modification after 7 days of aerobic exercise at 60–70 % of
the heart rate reserve, despite improvements in insulin
resistance and β-cell function [24]. These controversial ef-
fects of exercise training on Adpl are likely caused by vari-
ations in the training program (type, duration, intensity)
and different pathological contexts. Another point to be
considered in those discrepancies is the lack of data re-
garding Admer distribution and AdipoR expression. In-
deed, a recent study of Ad-KO mice suggested that the
absence of Ad does not impair the capacity of an 8-week
endurance training program to increase glucose and insu-
lin tolerance [26]. Although AdipoR expression has not
been investigated, compensatory mechanisms involving
AdipoR1 were hypothesized to explain the maintenance of
insulin sensitivity [26].
In brief, when exercise training is beneficial in MetS,
the contribution of Ad to this effect is still controversial.
Compensatory mechanisms involving the AdipoR recep-
tor have been suggested, but they seem to depend on
training intensity and duration. Therefore, to clarify the
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consequences of longer-term aerobic exercise on Ad ac-
tions in the context of MetS, we investigated the effect
of an 8-week aerobic treadmill training program on Ad
production via the assessment of plasmatic Admer distri-
bution and AdipoR1/AdipoR2 muscle expression in
high-fat diet (HF)-fed mice.
Methods
All procedures met the Belgian national standard re-
quirements regarding animal care and were conducted
in accordance with the Ethics and Welfare Committee
of the University of Mons.
Animals and diet
The experiments were performed on male C57BL6J mice
bred in our animal facility (accreditation number
LA1500022). The mice were housed in cages with ad libi-
tum access to water and food and were maintained at 35–
40 % relative humidity and a temperature of 20–23 °C in a
12:12 h light–dark cycle. At the age of 6 weeks, the ani-
mals were randomized to a standard (SF) or a high-fat
high-sugar (HF) diet. In addition to a standard vitamin
and mineral mix, the SF group received pellets consisting
of 70 % energy from complex carbohydrates (corn starch),
20 % protein, and 10 % fat (D12450K-Research Diet, Inc.,
New Brunswick, NJ, USA), whereas the HF diet was com-
posed of 20 % refined carbohydrates (7 % sucrose and
13 % maltodextrin), 20 % protein, and 60 % saturated and
mono-unsaturated fat, primarily from lard (D12492-Re-
search Diet, Inc., New Brunswick, NJ, USA). Food intake
and body weight were measured once a week during a 10-
week exposure period. The day following the end of the
protocol, mice were sacrificed, blood and tissues were col-
lected for RT-qPCR, ELISA and western blot analysis.
Exercise training protocol
After two weeks (at the beginning of week 3), the SF and
HF animals were randomly assigned to exercise-trained
(respectively SFT and HFT) or untrained (SFC and HFC)
groups. Control mice were not exposed to exercise ses-
sion and stayed in their cages during the protocol. The
mice were exercised on a treadmill (Treadmill Control
LE8700, Panlab apparatus®, Barcelona, Spain), 5 days a
week for 8 weeks. They were acclimated to the treadmill
at 3 m/min for 5 min and 9 m/min for 10 min during
weeks 3 and 4. At the beginning of week 5, an incremen-
tal test was performed with a gradual speed increase of
1.2 m/min every 2 min. For each mouse, exercise was
considered maximal and the test was interrupted when
the animal was unable to continue running at the belt
speed despite receiving four electric stimulations in one
minute. From weeks 5 to 10, the belt speed during train-
ing was set at 70 % of the maximal running velocity, and
the exercise duration was increased by 10 min per week
until a maximum of 60 min was reached. Both trained
groups were running at the same velocity. Mean ± SEM
of the 70 % of the maximal running velocity of trained
groups are detailed in the supporting information (Add-
itional file 1: Table S1).
Glucose tolerance test
After an overnight fast and 18 h after the last exer-
cise session, a glucose tolerance test (GTT) was per-
formed before the protocol, after week 2 of the
protocol and at the end of the protocol. A dose of
2 g/kg body weight of D-glucose (Roth, Karlsruhe,
Germany) was administered intraperitoneally. Blood
samples were then obtained from the caudal vein, and
the blood glucose level was measured 0, 30, 60, and
120 min after glucose injection using a One Touch®
Vita® glucometer (Zug, Switzerland).
MRI
Fat mass and lean body mass were measured using mag-
netic resonance imaging (MRI) analysis (PharmaScan 7 T,
Bruker®, Billerica, MA, USA) at the same time-points as
the GTT. The animal was anesthetized by 1.0–2.5 % iso-
flurane and restrained within a mouse-sized tube. Acquisi-
tion was synchronized with the respiratory cycle to
minimize physiological artefacts. The region of interest
was located between the upper pole of the kidney and the
feet. The imaging parameters for the 3D Fisp sequence are
detailed in the supporting information (Additional file 1:
Table S2). All the 3D images were segmented manually
(muscle) or automatically (fat) by the same operator using
Slicer 3D. Threshold levels were defined to discriminate
the tissue of interest (muscle: 6000–13,000, fat <12,500)
and the corresponding voxels were quantified.
RNA extraction – reverse transcription and real-time PCR
The total RNA from frozen visceral adipose tissue was
extracted using the miRNeasy Micro Kit (Qiagen®,
Hilden, Germany) according to the manufacturer’s in-
structions. The same amount of RNA was reverse tran-
scribed into cDNA with SuperScript® III First-Strand
Synthesis SuperMix (Invitrogen™, Carlsbad, CA, USA).
The qPCR was performed with Lightcycler 480 Real-Time
PCR II (F. Hoffmann Roche®, Ltd., Basel, Switzerland).
The cycling conditions were as follows: 30 s at 92 °C,
40 cycles of 30 s at 64 °C, and 15 s at 72 °C. All samples
were run in duplicate. The primers used for Ad and
GAPDH are detailed in the supporting information
(Additional file 1: Table S3). The target gene cycle
threshold (Ct) was normalized to the expression of the
housekeeping gene GAPDH, and gene expression was cal-
culated using the δδCt method.
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ELISA
The Ad and leptin concentrations were measured ac-
cording to the manufacturer’s instructions (Ad: MRP300,
leptin: MOB00, R&D Systems, Minneapolis, MN, USA).
Western blot
The relative amounts of LMW, MMW and HMW Admer
were determined using a non-denaturing PAGE-SDS
followed by a Western blot. To this aim, 5 μl of plasma
diluted to contain 5 μg/ml of Ad was loaded onto 6 %
polyacrylamide gel in the presence of SDS. The AdipoR
expression level was determined on frozen muscle tissue
(gastrocnemius) homogenized in a lysis buffer (Cell lytic
MT Mammalian Tissue Lysis/Reagent, Sigma-Aldrich,
St. Louis, MO, USA) containing a protease inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO, USA). Fifty mi-
crograms of total protein extract were then separated
using a 12 % denaturant PAGE-SDS. A peptide competi-
tion assay was performed to confirm the specificity of
each AdipoR antibody. To this aim, the antibody was
pre-incubated with or without the peptide prior to the
Western blot experiments. Moreover, cross-reactivity
with the appropriate AdipoR was also controlled for
each antibody. For the Western blot, proteins were
transferred to a nitrocellulose membrane (Millipore,
Darmstadt, Germany). After blocking with 5 % fat-free
dry milk-TBS, the membranes were incubated with
rabbit polyclonal primary antibody directed against Ad
(Ab85827, 1:1000, Abcam, Cambridge, UK), against
AdipoR1 (1:1000) or AdipoR2 (1:750) (AdipoR12-A,
AdipoR22-A; Alpha Diagnostic, San Antonio, TX, USA).
For standardization, the membranes were stripped, and
immunostaining was performed with a mouse polyclonal
antibody against GAPDH (Am4300, 1:5000, Invitrogen™,
Carlsbad, CA, USA). The membranes were then incu-
bated with a horseradish peroxidase-labeled secondary
antibody (1:5000, Sigma-Aldrich, St. Louis, MO, USA).
The ECL™ Western Blotting Detection kit (GE Health-
care, Little Chalfont, UK) was used for the revelation
step. The immunoreactive bands were then submitted to
a densitometric analysis using the Image J software.
Statistical analysis
For the sake of comparison, food intake values were aver-
aged for the first 2 weeks (week 2) and the last 8 weeks
(week 10). Using a least-square linear regression, we evalu-
ated the change in body weight over time from week 0 to
week 10 and calculated the slope coefficient for each ani-
mal. Lean and fat mass values are presented as the ratios of
week 2/week 0 and week 10/week 2 (considered the week
2 and week 10 values, respectively). The statistical analyses
of lean body mass, fat mass and body weight were deter-
mined using a Mann-Whitney rank sum test (week 2).
Food intake and glucose tolerance were assessed using
Student’s t-test (week 2) and one-way ANOVA followed by
Holm-Sidăk test (week 10). The ANOVA on ranks was
used to determine the statistical significance of the slope
body weight, body weight at week 10, lean and fat mass
(week 10), Ad mRNA, Adpl level and Admer distribution.
Finally, AdipoR1 and AdipoR2 muscle expression were
compared using two-way ANOVA followed by Holm-
Sidăk test. Differences were considered statistically signifi-
cant at a P value < 0.05. All data were represented as mean
± sem or boxplot (5 and 95th percentile) for parametric or
non-parametric statistical tests, respectively.
Results
Exercise training limits food intake and prevents body
weight gain and fat mass accumulation in HF-fed mice
To evaluate the effect of exercise training, standard (SF)
and high-fat high-sugar (HF) fed animals were submitted
to a training program (SFT and HFT) and compared to
control animals (SFC and HFC). The experimental de-
sign is presented in Fig. 1a. The evolution of body
weight and food intake are illustrated in Fig. 1b and c,
respectively. Compared with controls, the HF mice had
significantly increased food intake during weeks 1 and 2
(Fig. 1c, p < 0.001). During the training period, this dif-
ference was only maintained in the non-exercising HFC
animals (Fig. 1c, p < 0.001). This was associated with a
greater increase in body weight at the end of week 2 in
the HFC and HFT groups. During the training period,
the slope of the relationship of body weight over time
was significantly higher for the HFC group compared
with the three other groups (Fig. 1b, p < 0.001).
To determine whether the observed body weight varia-
tions reflected modifications in fat or lean body mass,
MRI analyses were performed. When the fat mass at
week 2 was expressed as a percentage of the value at
week 0, a higher increase was observed in the HF groups
compared with the SF groups (Fig. 2a, p < 0.05). When
the same ratio was calculated for the end to the begin-
ning of the training period, the change in fat body mass
was significantly reduced in the HFT group compared
with HFC group, and the HFT group was not different
from the SF groups (Fig. 2b, p < 0.001). The lean body
mass was not modified by HF diet or training (Fig. 2d).
As expected, our training conditions were able to reverse
the adverse effects of an HF diet on body weight through
a limitation of fat mass accumulation.
Exercise training improves the glucose tolerance of
HF-fed mice
After 2 weeks of the HF diet (Fig. 3a), the AUC of gly-
cemia during the GTT was increased (HF group week 2
vs week 0, p < 0.001; HF vs SF group week 2, p < 0.05) but
was not altered under the standard diet (SF group week 2
vs week 0, NS). At week 10, the AUC of the HFC group
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was higher than that of the three other groups (Fig. 3b, p
< 0.002). When exercise training was associated with an
HF diet, the increase in the AUC was limited but was not
restored to the same level as that of the SF diet groups (p
< 0.05).
HF diet induced an Admer redistribution that was not
reverted by exercise training
To clarify whether the beneficial effects of the aerobic
exercise program were associated with modulations of
Ad expression or secretion, we first evaluated the Ad
mRNA expression in visceral adipose tissue and total
Adpl levels. We did not observe any modification with
an HF diet or training (Fig. 4a-b), except when the
Adpl data were expressed in proportion to fat mass
(Fig. 4c, p < 0.001). Ad production and secretion ad-
justed in this manner were reduced with the HF diet
and improved with training, but the total level of cir-
culating Ad was not modified. In parallel, we found
an increased leptin concentration in HF-fed mice
compared with SF groups (Fig. 4d, p < 0.001). Upon
training, leptin level in HF-fed mice was still higher
compared with SFT group but not statistically different
from control mice.
Because Ad circulates in different multimeric forms, we
quantified the plasmatic proportion of LMW, MMW and
HMW Admer. We observed that the proportion of HMW
forms decreased in the HF-fed mice compared with con-
trol animals (Fig. 5a, p < 0.05). This reduction seemed to
be in favor of the LMW forms as shown in Additional
file 1: Figure S1a. By contrast, the distribution was not
different in the trained and untrained groups (Fig. 5a
and Additional file 1: Figure S1b). We also calculated the
SA index, defined as the ratio HMW/(HMW+LMW),
and reported as a more relevant indicator of insulin sensi-
tivity [27]. We found a reduction of SA index in HF-fed
mice compared with control mice (Fig. 5b), in accordance
with a reduction of HMW in favor of the LMW forms.
However, the effect of training was not sufficient to coun-
teract this redistribution induced by an HF diet.
HF diet and exercise training are responsible for distinct
modulation of the AdipoR muscle expression pattern
Exercise training induced a significant increase in the
AdipoR1 muscle level in mice submitted to a standard diet
(Fig. 6a, p < 0.05). However, no difference was observed
between the trained or untrained HF - fed mice, suggesting
that the induction of an increase in AdipoR1 protein via
exercise training is impaired by an HF diet. In contrast, we
observed a significantly increased AdipoR2 expression level
in the sedentary HF-fed mice compared with the SF-fed ani-
mals (Fig. 6b, p < 0.05). This effect of an HF diet on AdipoR2
muscle expression is no longer observed when exercise
training is performed simultaneously.
Discussion
Exercise training can counteract the adverse effects of an
HF diet in mice
MetS is a growing public health burden throughout the
world that can be treated by changing lifestyle behaviors.
Fig. 1 Effect of diet and exercise training on body weight and food intake. a Timeline. b Body weight evolution. Mean ± sem. * p < 0.001 slope
comparison, HFC vs all groups, ANOVA on ranks. c Food intake evolution. Mean ± sem. # p < 0.001, HF vs SF, t-test; * p < 0.001, HFC vs all groups,
One way ANOVA. GTT: glucose tolerance test, MRI: magnetic resonance imaging, HF: high-fat high-sugar diet, SF: standard diet
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Among these, exercise training is well known as a major
therapeutic strategy against MetS. In this study, mice ex-
posed to 10 weeks of an HF diet recapitulated the key
problems of MetS [28]: an increased caloric intake,
reflecting reduced satiety control, as well as increased
body weight and fat mass associated with impaired glu-
cose tolerance. Paradoxically, these disturbances were
associated to an increased plasmatic leptin level, a
hormone reducing food intake and increasing energy
expenditure, insulin sensitivity and fat deposition [29].
These results could be explained by a leptin resist-
ance, preventing its central and peripheral functions
[30]. In mice that consumed the same HF diet in as-
sociation with aerobic exercise training, a modifica-
tion of nutrition-related behavior was observed that
resulted in better food-intake and body-weight con-
trol. While the increased energy expenditure associ-
ated with exercise could participate to its beneficial
effects, an improvement of appetite control during
chronic exercise is also well described in the literature
[31, 32]. Although mechanisms remain to be eluci-
dated, modulations of fat-free mass and fat mass as
well as change in hormones such as leptin become
recognized as the most important components in-
volved in energy intake regulation during physical ac-
tivity [33]. In our study, we observed an attenuation
of hyperleptinemia upon training, in keeping with an
improvement of leptin regulation induced by a higher
energy expenditure [29, 34]. Associated to the better
food intake control in trained HF mice, our data are
in accordance with other studies suggesting that exer-
cise training reduces leptin resistance [35–37].
As expected, we also found in trained HF animals that
fat mass was maintained at the level of the controls, and
glucose intolerance was partly but significantly im-
proved. These observations corroborated the results of
Fig. 2 Effect of diet and exercise training on fat and lean mass. a Fat mass evolution during the untrained period. Fat mass was measured using MRI,
and the ratios are represented as boxplots (5 and 95th percentile). * p < 0.05, HF vs SF, Mann-Whitney rank sum test. b Fat mass evolution between
weeks 2 and 10. Ratios are represented as boxplots (5 and 95th percentile). * p < 0.001, HFC vs SFT and HFT, ANOVA on ranks. c Representative MR
Images obtained for SF- (left) and HF-fed (right) mice. Positive signal for adipose tissue. d Lean mass evolution between weeks 2 and 10. Ratios are
represented as boxplots (5 and 95th percentile). ANOVA on ranks: NS
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Gomes et al., showing that exercise ameliorated insulin
hypersecretion from pancreatic islets of HF diet rats
[38]. An increased GLUT4 expression was also observed
in trained subjects with MetS [39, 40] and could partici-
pate to the decreased glucose intolerance. These studies
coupled with our results confirmed that physical activity
provides numerous health-related benefits that prevent
the development of MetS, whether directly through its
effect on skeletal muscle and energy expenditure or in-
directly by changing nutrition behavior. In this context,
the contribution of Ad remains to be shown.
HF feeding alters Ad production and modifies Admer
distribution
Adpl is known to be inversely correlated with body
weight and fat mass (especially visceral fat) and posi-
tively correlated with HDL concentration [41], as shown
in obese patients compared with lean subjects [42–44]
and in HF-fed mice compared with animals consuming
a standard diet [45]. In our study, the Ad production per
unit of fat mass was reduced with the consumption of
an HF diet, suggesting adipose tissue dysfunction. How-
ever, the HF diet did not modify the total level of circu-
lating Ad, likely because of the concomitant increase of
fat mass and therefore of the number of Ad-producing
cells. These results were corroborated by Barnea et al.
[46] and Ribot et al. [47], who did not find any Adpl vari-
ation after exposure to an HF diet. In these studies, by
adjusting Ad levels to the weight of the white adipose
tissue mass, the authors revealed a significant reduction
of serum Ad in HF-fed mice. This reduction was associ-
ated to an increased circulating leptin level in HF-fed
mice. While Ad and leptin were described as two inde-
pendent factors which are dysregulated in MetS [48],
recent studies found that leptin could induce Ad expres-
sion in differentiated human white preadipocytes [49], in
ob/ob [50, 51] and in LDLR-/- mice [51]. Singh et al. also
suggested that leptin resistance may contribute to the re-
duced Ad expression in obese patients [49]. However,
further in vivo and clinical investigations are necessary to
confirm any causal relationship between leptin level and
Ad expression. Despite the absence of variation in the
Fig. 3 Effect of diet and exercise training on glucose tolerance. a Change in GTT after 2 weeks of an HF diet. Fasted mice were submitted to an
intraperitoneal injection of glucose (2 g/ kg b.w.). Glycemia was measured before (0) and 30, 60 and 120 min after injection. Histograms represent
the area under the curve (AUC) of glycemia from 0 to 120 min. Mean ± sem. * p < 0.05, HF vs SF, t-test; # p < 0.001, HF week 2 vs HF week 0,
paired t-test. b GTT at week 10. The left panel represents glycemia at the different time-points, and the right panel represents the AUC. Mean ±
sem. * p≤ 0.002, HFC vs all groups; # p < 0.05, HFT vs all groups, one-way ANOVA
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absolute amount of Ad in the bloodstream, we observed a
modification of Admer distribution that was characterized
by a decreased level of HMW forms in favor of LMW
multimers. This decrease was also observed by Anderson
et al. [52] and was suggested by Nakashima et al. to
predict the existence of MetS [53]. In accordance with this
reduction of HMW forms, we observed a reduction of SA
index in HF-fed mice compared with control mice. These
results were corroborated by Pajvani et al. [27] which
observed a decreased SA index in db/db mice and in type
II diabetic patients compared with control mice and
insulin-sensitive individuals, respectively, despite similar
total Ad levels. These data reinforce the importance of
investigating Admer distribution in the diagnosis of MetS,
even in the absence of a change in the total Adpl level
[54].
HF feeding increases muscle expression levels of AdipoR2
but not AdipoR1
Regarding AdipoR expression with HF feeding, Blüher et
al. [55] suggested that AdipoR2 upregulation could be a
compensatory mechanism in response to reduced Adpl.
This hypothesis was reinforced by Bauche et al. [56], who
suggested the existence of a regulatory feedback loop by
which Ad downregulates its own production and its
AdipoR2-receptor expression in adipose tissue.
Fig. 4 Ad and leptin analysis at week 10. a Ad expression in adipose tissue. The Ad mRNA level in abdominal fat was determined by RTqPCR (Syber
Green). Data are represented as boxplots (5 and 95th percentile). ANOVA on ranks: NS. b and c Ad plasmatic level. The total Adpl concentration was
measured using indirect ELISA. Data are represented as boxplots (5 and 95th percentile). Panel b) ANOVA on ranks: NS. Panel c) Adpl level normalized for
fat mass. * p< 0.001, SFT vs HFT and HFC; #: p< 0.001, HFC vs SFC; ANOVA on ranks. d Leptin plasmatic level. The leptin concentration was measured
using indirect ELISA. Data are represented as boxplots (5 and 95th percentile). * p< 0.001, HFC vs SFC and SFT; #: p< 0.001, HFT vs SFT; ANOVA on ranks
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Interestingly, we found an increased AdipoR2 expres-
sion in HF-fed mice in the absence of any Adpl modifi-
cation. Therefore, it seems reasonable to hypothesize
that this modified AdipoR level could be caused by
compensatory mechanisms in response to a reduced
level of HMW forms.
In contrast to AdipoR2, the AdipoR1 muscle expression
level was not modified with the HF diet. This differential
effect of HF feeding draws attention to the distinct func-
tion of these receptors. Parker-Duffen et al. [11] recently
observed that AdipoR2-deficient mice submitted to hind-
limb ischemic surgery exhibited severely attenuated revas-
cularization, whereas AdipoR1-deficient mice exposed to
an HF diet developed metabolic perturbations character-
ized by a greater body weight and fat mass, hepatic
steatosis, impaired glucose tolerance. These results were
corroborated by previous studies observing that AdipoR1-
KO mice exhibited increased glucose intolerance after HF
feeding [57], whereas AdipoR2-KO mice were resistant to
these effects [57, 58, 10]. In concordance with these stud-
ies, the increased AdipoR2 muscle expression observed
here was not able to counteract the adverse effects of an
HF diet on glucose homeostasis and fat mass in the ab-
sence of a change in AdipoR1 expression. Different mech-
anisms have been suggested to explain the different
functionalities of AdipoR [211]: (i) AdipoR1 and AdipoR2
exert their effects through different signaling pathways:
AMPK and PPAR-α, respectively; (ii) potential Ad-binding
proteins, such as the adaptor proteins calreticulin and T-
cadherin, could modulate AdipoR functions; (iii) The Adi-
poR1 and AdipoR2 expression pattern and function have
been reported to be tissue-specific.
Fig. 5 Admer distribution analysis at week 10. The proportions of high (HMW), medium (MMW) and low (LMW) molecular weight Admer were
determined using non-denaturant PAGE-SDS followed by a Western blot. a Admer/total Ad ratio obtained after densitometric analysis. Data are
represented as boxplots (5 and 95th percentile).*, # p < 0.001 vs SFC, Mann-Whitney rank sum test. b SA index was calculated as the ratio HMW/
(HMW+ LMW). Data are represented as boxplots (5 and 95th percentile).* p < 0.001 HFC vs SFC and SFT; # p < 0.001, HFT vs SFC, Mann-Whitney
rank sum test. c Representative blots
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An 8-week exercise training program has limited effects
on Adpl and Admer distribution with an HF diet
In our study, the altered Adpl-to-fat mass ratio suggested
that Ad secretion by adipose tissue was improved by
training. The total level of circulating Ad, however, was
not modulated. Such results are often discussed in terms
of body weight variation during the training period. In-
deed, a threshold value of 10 % body weight reduction
was suggested to be required before increased Adpl
would be observed [59–61]. This was contradicted by
Saunders et al. [25], who found that in humans, physical
activity was able to increase Adpl without any change in
body weight. Our study design associated a training pro-
gram with HF feeding and the trained HF mice did not
exhibit any weight loss throughout the protocol. Ad level
was thus not influenced by a declining body weight dur-
ing the training program. Trained HF mice maintained
their body weight at the level of control animals, most
probably due to the effect of exercise training on appe-
tite control. The benefit observed on Adpl-to-fat mass
ratio could likely reflect the effect of exercise training,
either directly or through its effect on food intake.
Regarding Admer distribution, the effect of exercising
led to contrasting results in the literature. An absence of
Admer modulation upon training was observed by Ando
et al. [61] after 12 weeks of combined resistance and aer-
obic exercise in Japanese participants. Other studies re-
ported an increased HMW level after 12 weeks of
aerobic exercise in obese adults with insulin resistance
[62] and after 24 weeks of walking in obese middle-aged
women [63]. Our results showed that the HMW propor-
tion was significantly decreased in untrained HF mice
but not in trained HF mice when compared with con-
trols. However, the difference in the HMW proportion
Fig. 6 AdipoR muscle expression analysis at week 10. a and c The relative expression of AdipoR1 was determined using a PAGE-SDS followed by a
Western blot using specific antibodies. GAPDH was used as the loading control. The upper panel represents the results obtained after densitometric
analysis. The lower panel shows representative blots. Mean ± sem. * p < 0.05, SFT vs SFC and HFT, two-way ANOVA followed by Holm-Sidăk test. b and
d The relative expression of AdipoR2 was determined as described in (a). Mean ± sem. * p < 0.05, HFC vs HFT and SFC, two-way ANOVA followed by
Holm-Sidăk test
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between the trained and untrained HF groups did not
reach statistical significance. These discrepancies among
studies could be related to the type and duration of exer-
cise. Moreover, the different metabolic profiles observed
in these studies could also have differently influenced
the effect of training on Admer distribution [61–63]. Re-
garding this point, Garekani et al. [59] and Chang et al.
[64] suggested that the effect of exercise training on Adpl
could depend on the obesity of the subject.
An 8-week aerobic exercise training program increases
AdipoR1 muscle expression level, an effect that is
hampered by HF feeding
While the HF diet affected AdipoR2 levels, training in-
creased the AdipoR1 expression level in muscle without
modifying AdipoR2. This result was in agreement with
the potential segregated functions of these receptors in
muscle. Moreover, as only a slight and non-significant dif-
ference in body weight and food intake was observed
between trained and control mice, it is conceivable to at-
tribute AdipoR1 up-regulation to exercise training itself.
This hypothesis is reinforced by the study of Goto et al.
which observed a down-regulation of AdipoR1 mRNA in
atrophied soleus muscle after a 2-week hindlimb suspen-
sion [65]. This alteration is no longer observed after a 2-
week ambulation recovery protocol. Our data are thus in
accordance with an AdipoR1 up-regulation induced by
mechanical loading such as during exercise training.
Because of its role in metabolic homeostasis, the in-
crease in AdipoR1 could contribute, at least partly, to the
beneficial effect of exercise training. As it was reported
that AdipoR1 expression is negatively regulated by insulin
[14], it seems reasonable to hypothesize that AdipoR1 up-
regulation in SF trained mice may be consecutive to a
lower insulin level, as mentioned by Huang et al. [66]. In
transgenic animal models [64, 66] or obese subjects [62],
previous studies have found an increase in muscular
AdipoR1 mRNA [62, 66] and protein levels [55, 10] after
physical activity. However, as Farias et al. found in skeletal
muscle, we observed an opposite interaction of HF feeding
and exercise training on AdipoR1 level regulation [67].
Molecular mechanisms involved in this interaction are still
to determine, but FoxO and ATF3 signaling pathways
should be considered for further investigations [14].
In HF-fed animals, if exercise training reduced glucose
intolerance, the GTT response was not completely normal-
ized to the level of the control animals. Simultaneously, we
also observed that AdipoR1 upregulation by exercise is no
longer present upon HF feeding. Although other mecha-
nisms are most probably required, an association between
both results may be considered. In addition, we also have
to mention that in obese patients [57] and in HF-fed rats
[68], skeletal muscle Ad resistance has been described.
Although a downregulation of AdipoR has been
suggested, the causes at the basis of this phenomenon
are not completely known [69].
Conclusion
In conclusion, the HF-fed mice recapitulated the key
problems of MetS, despite compensatory mechanisms
involving AdipoR2 muscle expression. Our study also
showed that 8 weeks of exercise training could reduce
adipose tissue dysfunction and induce an increased level
of AdipoR1 in muscle. Upon HF feeding, a concomitant
aerobic exercise training prevented numerous metabolic
perturbations either directly or by modifying nutrition
behavior. However, HF feeding during a training pro-
gram hampered AdipoR1 upregulation in muscle. The
consecutive attenuation of Ad signaling could partly
limit the beneficial effects of exercise training on metab-
olism in the context of MetS. However, besides Ad path-
way, additional processes are likely involved in the
beneficial effects of exercise training on the metabolism
of HF-fed animals and should be further examined. Finally,
our study supports the growing evidence of divergent func-
tions of AdipoR1 and AdipoR2 receptors. It also highlights
that modulations of Admer distribution and AdipoR expres-
sion should be taken into consideration for the diagnosis
of MetS as well as for current therapeutic strategies
that aim to increase circulating Ad levels.
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